Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: April 1, 2023

SOAANZ Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $100
Remove trial restrictions

When do Soaanz patents expire, and when can generic versions of Soaanz launch?

Soaanz is a drug marketed by Sarfe Pharms and is included in one NDA. There is one patent protecting this drug.

This drug has two patent family members in two countries.

The generic ingredient in SOAANZ is torsemide. There are sixteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the torsemide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Soaanz

A generic version of SOAANZ was approved as torsemide by TEVA on May 14th, 2002.

  Sign Up

Summary for SOAANZ
International Patents:2
US Patents:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 126
Patent Applications: 4,658
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in SOAANZ?SOAANZ excipients list
DailyMed Link:SOAANZ at DailyMed
Drug patent expirations by year for SOAANZ
Pharmacology for SOAANZ
Drug ClassLoop Diuretic
Physiological EffectIncreased Diuresis at Loop of Henle

US Patents and Regulatory Information for SOAANZ

SOAANZ is protected by one US patents.

Patents protecting SOAANZ

Controlled-release formulations comprising Torsemide
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sarfe Pharms SOAANZ torsemide TABLET;ORAL 213218-001 Jun 14, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Sarfe Pharms SOAANZ torsemide TABLET;ORAL 213218-003 Nov 17, 2021 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sarfe Pharms SOAANZ torsemide TABLET;ORAL 213218-002 Jun 14, 2021 RX Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for SOAANZ

See the table below for patents covering SOAANZ around the world.

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 2015050570 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.